ISIS 1 Therapeutic Effectiveness

NCT00646477 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tyco Healthcare Group